Literature DB >> 18523722

LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.

Daniel Kam Yin Chan1, Ping Wing Ng, Vincent Mok, Jonas Yeung, Zhi Ming Fang, Raymond Clarke, Edward Leung, Lawrence Wong.   

Abstract

The frequency of LRRK2 Gly2385Arg mutation in Hong Kong Chinese with early-onset (age < or =45 years) Parkinson's disease was identified and compared with late-onset patients (age >50 years) and controls. The mutation prevalence were 8.8, 8.3, and 0% for early-onset, late-onset, and controls, respectively. The mean age of onset among LRRK2 G2385R carriers was 42.7 years old for early-onset compared to 74.3 for late-onset patients. LRRK2 G2385R mutation appears to be as prevalent among early-onset as late-onset patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523722     DOI: 10.1007/s00702-008-0065-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  13 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

Review 2.  Comparison of environmental and genetic factors for Parkinson's disease between Chinese and Caucasians.

Authors:  Daniel Kam Yin Chan; Dennis Cordato; Triet Bui; George Mellick; Jean Woo
Journal:  Neuroepidemiology       Date:  2004 Jan-Apr       Impact factor: 3.282

3.  The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.

Authors:  Chin-Song Lu; Erik J Simons; Yah-Huei Wu-Chou; Alessio Di Fonzo; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Christan F Rohé; Guido J Breedveld; Nobutaka Hattori; Thomas Gasser; Ben A Oostra; Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2005-10-26       Impact factor: 4.891

4.  Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Authors:  Daniela Berg; Katherine J Schweitzer; Petra Leitner; Alexander Zimprich; Peter Lichtner; Petra Belcredi; Theresa Brüssel; Claudia Schulte; Sylvia Maass; Thomas Nägele; Zbigniew K Wszolek; Thomas Gasser
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

5.  The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Authors:  E K Tan; Y Zhao; L Skipper; M G Tan; A Di Fonzo; L Sun; S Fook-Chong; S Tang; E Chua; Y Yuen; L Tan; R Pavanni; M C Wong; P Kolatkar; C S Lu; V Bonifati; J J Liu
Journal:  Hum Genet       Date:  2006-09-30       Impact factor: 4.132

6.  The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

Authors:  Cao Li; Zhang Ting; Xiao Qin; Wang Ying; Bai Li; Lu Guo Qiang; Ma Jian Fang; Zhang Jing; Ding Jian Qing; Chen Sheng Di
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

Review 7.  LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

Authors:  Julie P Taylor; Ignacio F Mata; Matt J Farrer
Journal:  Trends Mol Med       Date:  2006-01-10       Impact factor: 11.951

8.  PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.

Authors:  Daniel Kam Yin Chan; Vincent Mok; Ping Wing Ng; Jonas Yeung; John B Kwok; Zhi Ming Fang; Raymond Clarke; Lawrence Wong; Peter R Schofield; Nobutaka Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

9.  A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors:  William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

10.  A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.

Authors:  Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Andrew B Singleton; Yih-Ru Wu
Journal:  BMC Neurol       Date:  2006-12-22       Impact factor: 2.474

View more
  10 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

Review 2.  LRRK2 links genetic and sporadic Parkinson's disease.

Authors:  Jillian H Kluss; Adamantios Mamais; Mark R Cookson
Journal:  Biochem Soc Trans       Date:  2019-03-05       Impact factor: 5.407

3.  LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.

Authors:  Chao Gao; Hao Pang; Xiao-Guang Luo; Yan Ren; Hong Shang; Zhi-Yi He
Journal:  J Neurol       Date:  2013-08-30       Impact factor: 4.849

Review 4.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

Review 5.  Genetic susceptibility in Parkinson's disease.

Authors:  Jose Miguel Bras; Andrew Singleton
Journal:  Biochim Biophys Acta       Date:  2008-11-20

Review 6.  Genetics of Parkinson's disease - a clinical perspective.

Authors:  Sang-Myung Cheon; Lilian Chan; Daniel Kam Yin Chan; Jae Woo Kim
Journal:  J Mov Disord       Date:  2012-10-30

7.  The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies.

Authors:  Wei Di; Zhiyong Zeng; Jingyan Li; Xiaoling Liu; Minzhi Bo; Hua Lv
Journal:  Parkinsons Dis       Date:  2018-07-10

Review 8.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

Review 9.  LRRK2: cause, risk, and mechanism.

Authors:  Coro Paisán-Ruiz; Patrick A Lewis; Andrew B Singleton
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

10.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.